Table 3 Multivariate analysis results

From: Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: a clinical follow-up study of 110 patients

Variable

Coefficient

Standard error

Risk ratio

P -value

(A)

    

AJCC

0.8081

0.2983

2.2436

0.0067

Breslow thickness

0.0010

0.0004

1.0010

0.0098

Baseline tyrosinase*

0.6345

0.4192

1.8860

0.1302

(B)

    

AJCC

0.6186

0.3168

1.8563

0.05

Breslow thickness

0.0007

0.0004

1.0007

0.05

Follow-up tyrosinase*

1.4678

0.3662

4.3399

0.0001

  1. *Tyrosinase negative=0, Tyrosinase positive=1.
Back to article page